Behavioral stress causes mitochondrial dysfunction via ABAD up-regulation and aggravates plaque pathology in the brain of a mouse model of Alzheimer disease.

Basic and clinical studies have reported that behavioral stress worsens the pathology of Alzheimer disease (AD), but the underlying mechanism has not been clearly understood. In this study, we determined the mechanism by which behavioral stress affects the pathogenesis of AD using Tg-APPswe/PS1dE9 mice, a murine model of AD. Tg-APPswe/PS1dE9 mice that were restrained for 2h daily for 16 consecutive days (2-h/16-day stress) from 6.5months of age had significantly increased Aβ(1-42) levels and plaque deposition in the brain. The 2-h/16-day stress increased oxidative stress and induced mitochondrial dysfunction in the brain. Treatment with glucocorticoid (corticosterone) and Aβ in SH-SY5Y cells increased the expression of 17β-hydroxysteroid dehydrogenase (ABAD), mitochondrial dysfunction, and levels of ROS, whereas blockade of ABAD expression by siRNA-ABAD in SH-SY5Y cells suppressed glucocorticoid-enhanced mitochondrial dysfunction and ROS accumulation. The 2-h/16-day stress up-regulated ABAD expression in mitochondria in the brain of Tg-APPswe/PS1dE9 mice. Moreover, all visible Aβ plaques were costained with anti-ABAD in the brains of Tg-APPswe/PS1dE9 mice. Together, these results suggest that behavioral stress aggravates plaque pathology and mitochondrial dysfunction via up-regulation of ABAD in the brain of a mouse model of AD.

[1]  A. Chauhan,et al.  Oxidative stress in Alzheimer's disease. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.

[2]  F. Bian,et al.  Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.

[3]  D. Butterfield,et al.  Role of oxidative stress in the progression of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[4]  Takayoshi Inoue,et al.  Chronic stress-mutated presenilin 1 gene interaction perturbs neurogenesis and accelerates neurodegeneration , 2010, Experimental Neurology.

[5]  C. Catania,et al.  Stress and glucocorticoid footprints in the brain—The path from depression to Alzheimer's disease , 2008, Neuroscience & Biobehavioral Reviews.

[6]  D. Harman,et al.  Alzheimer's Disease Pathogenesis , 2006, Annals of the New York Academy of Sciences.

[7]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[8]  S. Paik,et al.  Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. , 2006, Free radical biology & medicine.

[9]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[10]  D. Borchelt,et al.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. , 2001, Biomolecular engineering.

[11]  D. Praticò.  Causes and Consequences of Oxidative Stress in Neurodegenerative Diseases , 2005 .

[12]  Heikki Tanila,et al.  Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice , 2003, Neurobiology of Disease.

[13]  Y. Leem,et al.  Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease. , 2010, Journal of Alzheimer's disease : JAD.

[14]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[15]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[16]  Bernardino Ghetti,et al.  The Genetics of Very Early Onset Alzheimer Disease , 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[17]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[18]  Lars Bertram,et al.  Genome-wide association studies in Alzheimer's disease. , 2009, Human molecular genetics.

[19]  R. Hamilton,et al.  Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[20]  D. Selkoe,et al.  Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. , 2003, Annual review of pharmacology and toxicology.

[21]  S. Yan,et al.  Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD) , 2005, International journal of experimental pathology.

[22]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[23]  J. Im,et al.  Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress , 2009, Journal of Neurochemistry.

[24]  D. Holtzman,et al.  Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity , 2007, Proceedings of the National Academy of Sciences.

[25]  S. Yan,et al.  Role of mitochondrial amyloid-beta in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[26]  A. Eckert,et al.  Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects , 2010, Molecular Neurobiology.

[27]  Y. Leem,et al.  SK-PC-B70M confers anti-oxidant activity and reduces Aβ levels in the brain of Tg2576 mice , 2009, Brain Research.

[28]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[29]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.

[30]  Xi Chen,et al.  ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  M. Smith,et al.  Causes of oxidative stress in Alzheimer disease , 2007, Cellular and Molecular Life Sciences.

[32]  B. Ames,et al.  The free radical theory of aging matures. , 1998, Physiological reviews.

[33]  P. Doraiswamy,et al.  Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. , 2003, Psychopharmacology bulletin.

[34]  B. McEwen,et al.  Dynamic regulation of mitochondrial function by glucocorticoids , 2009, Proceedings of the National Academy of Sciences.

[35]  M. Ball,et al.  Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A , 1994 .

[36]  Ji-Seon Seo,et al.  Oriental medicine Jangwonhwan reduces Abeta(1-42) level and beta-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease. , 2010, Journal of ethnopharmacology.

[37]  Shaharyar M. Khan,et al.  Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease. , 2006, Current Alzheimer research.

[38]  S. Leutner,et al.  ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain , 2001, Journal of Neural Transmission.

[39]  J. Csernansky,et al.  Corticosterone and related receptor expression are associated with increased β-amyloid plaques in isolated Tg2576 mice , 2008, Neuroscience.

[40]  C. Masters,et al.  Gelatinase A possesses a β‐secretase‐like activity in cleaving the amyloid protein precursor of Alzheimer's disease , 1995 .

[41]  P. Han,et al.  Optimization of chronic stress paradigms using anxiety‐ and depression‐like behavioral parameters , 2006, Journal of neuroscience research.

[42]  N. Bazan,et al.  Hypoxia signaling to genes , 2002, Molecular Neurobiology.

[43]  N. Durany,et al.  Oxidative stress in Alzheimer disease , 2009, Cell adhesion & migration.

[44]  G. Steele,et al.  Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Fagan,et al.  Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. , 2006, The American journal of psychiatry.

[46]  O. Almeida,et al.  Gender specificity in the neural regulation of the response to stress , 1998, Molecular Neurobiology.

[47]  J. Im,et al.  Nordihydroguaiaretic acid induces astroglial death via glutathione depletion , 2007, Journal of neuroscience research.

[48]  P. Emson,et al.  Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APP V717I -CT100 transgenic mice, an Alzheimer’s disease model , 2006 .

[49]  J. Leza,et al.  Glutathione Depletion, Lipid Peroxidation and Mitochondrial Dysfunction Are Induced by Chronic Stress in Rat Brain , 2001, Neuropsychopharmacology.

[50]  J. Csernansky,et al.  Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress , 2004, Neuroscience.

[51]  D. Holtzman,et al.  Apolipoprotein E, amyloid, and Alzheimer disease. , 2002, Molecular interventions.

[52]  Raymond Scott Turner.  Alzheimer's disease in man and transgenic mice: females at higher risk. , 2001, The American journal of pathology.

[53]  J. Leza,et al.  Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain , 2003, Neuropsychopharmacology.

[54]  M. Mattson,et al.  Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[55]  S. Yan,et al.  Amyloid-β-Induced Mitochondrial Dysfunction , 2007 .

[56]  V. Henderson.  Estrogen, cognition, and a woman's risk of Alzheimer's disease. , 1997, The American journal of medicine.

[57]  Xi Chen,et al.  Mitochondrial dysfunction and Alzheimer's disease. , 2006, Current Alzheimer research.